*1963 in Switzerland, he joined T3 BioScience as their CEO in early 2016. His background is in economics with degrees from the Federal Business School of Commerce and a Swiss Federal Degree in Organization & Project Management. Prior to joining T3, Burgin spent 30+ years in the financial industry, eventually building his own business in Tokyo that was acquired by the New York Stock Exchange Group in 2011, for whom he continued to be the Executive Director, responsible for their Asia Pacific commercial technology division.
Chief Executive Officer
CEO, Investor & Member of the Board of Directors. He joined the Board in early 2016, when accepting his role as T3's CEO. Daniel Bürgin has a Swiss federal degree in economics and 30 years experience in capital markets. Prior to T3 he was founder and CEO of his own startup, which he successfully sold to the New York Stock Exchange Group in 2011, for whom he was managing their APAC business as Senior Vice President.